Cresco Labs (CRLBF) EBIT Margin (2020 - 2026)

Cresco Labs (CRLBF) posted EBIT Margin of 7.38% for Q1 2026, up 115.79% on a QoQ basis from 46.76% in Q4 2025, and down 81.0% year-over-year from 38.86% in Q1 2025.

Cresco Labs (CRLBF) EBIT Margin (2020 - 2026) Analysis & Trends

Cresco Labs' EBIT Margin history runs 7 years deep, the most recent figure standing at 7.38% for Q1 2026.

  • Quarterly EBIT Margin fell 81.0% year-over-year to 7.38% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 4.74% (down 1773.0% YoY) and the FY2025 annual result came in at 4.27%, down 1908.0% from the prior year.
  • EBIT Margin was 7.38% for Q1 2026 at Cresco Labs, up from 46.76% in the prior quarter.
  • Across five years, EBIT Margin topped out at 17.56% in Q2 2024 and bottomed at 71.89% in Q4 2022.
  • A 5-year average of 2.44% and a median of 9.45% in 2022 frame the typical range for EBIT Margin.
  • Peak annual rise in EBIT Margin reached 13024 bps in 2022, while the deepest fall reached 7903 bps in 2022.
  • Cresco Labs' EBIT Margin stood at 71.89% in 2022, then soared by 120 bps to 14.4% in 2023, then decreased by 23 bps to 11.03% in 2024, then slumped by 524 bps to 46.76% in 2025, then soared by 116 bps to 7.38% in 2026.
  • Business Quant data shows CRLBF's EBIT Margin at 7.38% in Q1 2026, 46.76% in Q4 2025, and 10.81% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 16.37%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 36.83%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -38.02%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 41.69%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -2.27%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 23.74%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 21.23%
10 Cresco Labs 254.96 Mn 99.57 Mn 75.45 Mn 7.38%

Historic Data

Download Data
DateValue
Mar 31, 2026 7.38%
Dec 31, 2025 -46.76%
Sep 30, 2025 10.81%
Jun 30, 2025 9.86%
Mar 31, 2025 8.20%
Dec 31, 2024 11.03%
Sep 30, 2024 14.65%
Jun 30, 2024 17.56%
Mar 31, 2024 15.82%
Dec 31, 2023 14.40%
Sep 30, 2023 -56.55%
Jun 30, 2023 -5.43%
Mar 31, 2023 1.85%
Dec 31, 2022 -71.89%
Sep 30, 2022 7.72%
Jun 30, 2022 10.39%
Mar 31, 2022 9.45%
Dec 31, 2021 7.14%
Sep 30, 2021 -122.52%
Jun 30, 2021 7.08%